Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
Interventions
- BIOLOGICAL: carcinoembryonic antigen-expressing measles virus
- BIOLOGICAL: oncolytic measles virus encoding thyroidal sodium iodide symporter
- GENETIC: reverse transcriptase-polymerase chain reaction
- OTHER: laboratory biomarker analysis
Sponsor
Mayo Clinic
Collaborators